跳至主要内容
临床试验/NCT05318300
NCT05318300进行中(未招募)不适用

Assessment of the Effect of Cow's Milk Protein-based Formulas for Infants in the Management of Moderate to Severe aTOPic Dermatitis in Infants Aged Less Than 18 Months

United Pharmaceuticals3 个研究点 分布在 2 个国家目标入组 126 人开始时间: 2022年5月24日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
126
试验地点
3
主要终点
EASI (Eczema Area Severity Index) score after 90 days.

研究概览

简要总结

The aim of this study is to show the efficiency of a new infant formula containing fiber on the management of moderate to severe atopic dermatitis.

详细描述

The study is double blind randomized where the new formula is compared to a placebo during 3 months followed by a period of 3 months optional. During this period of time, all infant include in the study will be fed with the study formula.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Month 至 18 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Aged below 18 month
  • Having an atopic dermatitis diagnosed according to the United Kingdom Working Party - Having an Eczema Area Severity Index (EASI) between 7.1 and 50.0
  • Whose parents gave their informed consent

排除标准

  • systemic corticotherapy
  • antihistamine
  • use of dermocorticoide and/or antibiotics within 15 days
  • symptoms of cutaneous infection
  • Past anaphylactic shock
  • cow's milk, soya or fish allergy
  • Exclusive or predominant breast feediing (more than one feeding/day)
  • Consumption of less than 500 ml per day
  • Participation to another trial.

结局指标

主要结局

EASI (Eczema Area Severity Index) score after 90 days.

时间窗: 90 days

evolution of the EASI score between day 0 to day 90. The score range is between 0 (no eczema) and 72 (highest score of eczema)

次要结局

  • Skin dryness(180 days)
  • EASI (Eczema Area Severity Index) score after 30 days.(30 days)
  • EASI (Eczema Area Severity Index) score after 60 days.(60 days)
  • Satisfaction of the investigator(Day 180)
  • EASI (Eczema Area Severity Index) score after 180 days.(180 days)
  • PO SCORAD (Patient Oriented-SCORing Atopic Dermatitis ) evolution(180 days)
  • Itching(180 days)
  • Quality of sleep (assessed by VAS)(180 days)
  • Weight(180 days)
  • Use of topical dermocorticoids(180 days)
  • Length/Height(180 days)
  • Stool's frequency(Day 180)
  • Atopic dermatitis flare(180 days)
  • Regurgitations(Day 180)
  • Stool's consistency(Day 180)
  • Gas, bloating(Day 180)
  • Satisfaction of the parents(Day 180)
  • Sleep time(180 days)
  • IDQoL (Infant's Dermatitis Quality of Life)(90 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验